Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD

Abstract Background COPD is a complex, heterogeneous disease characterised by progressive development of airflow limitation. Spirometry provides little information about key aspects of pathology and is poorly related to clinical outcome, so other tools are required to investigate the disease. We sou...

Full description

Bibliographic Details
Main Authors: Kristoffer Ostridge, Nicholas P. Williams, Viktoriya Kim, Stephen Harden, Simon Bourne, Stuart C. Clarke, Emmanuel Aris, Sonia Mesia-Vela, Jeanne-Marie Devaster, Andrew Tuck, Anthony Williams, Stephen Wootton, Karl J. Staples, Tom M. A. Wilkinson, on behalf of the AERIS Study Group
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Respiratory Research
Subjects:
CT
Online Access:http://link.springer.com/article/10.1186/s12931-018-0734-y
id doaj-41f34bc8aa6d44ee96ae5e3ea5ad1a66
record_format Article
spelling doaj-41f34bc8aa6d44ee96ae5e3ea5ad1a662020-11-25T00:59:37ZengBMCRespiratory Research1465-993X2018-02-0119111110.1186/s12931-018-0734-yRelationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDKristoffer Ostridge0Nicholas P. Williams1Viktoriya Kim2Stephen Harden3Simon Bourne4Stuart C. Clarke5Emmanuel Aris6Sonia Mesia-Vela7Jeanne-Marie Devaster8Andrew Tuck9Anthony Williams10Stephen Wootton11Karl J. Staples12Tom M. A. Wilkinson13on behalf of the AERIS Study GroupClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonDepartment of Radiology, University Hospital Southampton NHS Foundation TrustClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonGSK VaccinesGSK VaccinesGSK VaccinesFaculty of Medicine and Institute for Life Sciences, University of SouthamptonClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonNIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation TrustClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonClinical and Experimental Sciences, Faculty of Medicine, University of SouthamptonAbstract Background COPD is a complex, heterogeneous disease characterised by progressive development of airflow limitation. Spirometry provides little information about key aspects of pathology and is poorly related to clinical outcome, so other tools are required to investigate the disease. We sought to explore the relationships between quantitative CT analysis with functional, inflammatory and infective assessments of disease to identify the utility of imaging to stratify disease to better predict outcomes and disease response. Methods Patients from the AERIS study with moderate-very severe COPD underwent HRCT, with image analysis determining the quantity of emphysema (%LAA<− 950), small airways disease (E/I MLD) and bronchial wall thickening (Pi10). At enrolment subjects underwent lung function testing, six-minute walk testing (6MWT), blood sampling for inflammatory markers and sputum sampling for white cell differential and microbiological culture and PCR. Results 122 subjects were included in this analysis. Emphysema and small airways disease had independent associations with airflow obstruction (β = − 0.34, p < 0.001 and β = − 0.56, p < 0.001). %LAA<− 950 had independent associations with gas transfer (β = − 0.37, p < 0.001) and E/I MLD with RV/TLC (β = 0.30, p =0.003). The distance walked during the 6MWT was not associated with CT parameters, but exertional desaturation was independently associated with emphysema (β = 0.73, p < 0.001). Pi10 did not show any independent associations with lung function or functional parameters. No CT parameters had any associations with sputum inflammatory cells. Greater emphysema was associated with lower levels of systemic inflammation (CRP β = − 0.34, p < 0.001 and fibrinogen β = − 0.28, p =0.003). There was no significant difference in any of the CT parameters between subjects where potentially pathogenic bacteria were detected in sputum and those where it was not. Conclusions This study provides further validation for the use of quantitative CT measures of emphysema and small airways disease in COPD as they showed strong associations with pulmonary physiology and functional status. In contrast to this quantitative CT measures showed few convincing associations with biological measures of disease, suggesting it is not an effective tool at measuring disease activity.http://link.springer.com/article/10.1186/s12931-018-0734-yCOPDCTImagingPhenotypingEmphysema
collection DOAJ
language English
format Article
sources DOAJ
author Kristoffer Ostridge
Nicholas P. Williams
Viktoriya Kim
Stephen Harden
Simon Bourne
Stuart C. Clarke
Emmanuel Aris
Sonia Mesia-Vela
Jeanne-Marie Devaster
Andrew Tuck
Anthony Williams
Stephen Wootton
Karl J. Staples
Tom M. A. Wilkinson
on behalf of the AERIS Study Group
spellingShingle Kristoffer Ostridge
Nicholas P. Williams
Viktoriya Kim
Stephen Harden
Simon Bourne
Stuart C. Clarke
Emmanuel Aris
Sonia Mesia-Vela
Jeanne-Marie Devaster
Andrew Tuck
Anthony Williams
Stephen Wootton
Karl J. Staples
Tom M. A. Wilkinson
on behalf of the AERIS Study Group
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
Respiratory Research
COPD
CT
Imaging
Phenotyping
Emphysema
author_facet Kristoffer Ostridge
Nicholas P. Williams
Viktoriya Kim
Stephen Harden
Simon Bourne
Stuart C. Clarke
Emmanuel Aris
Sonia Mesia-Vela
Jeanne-Marie Devaster
Andrew Tuck
Anthony Williams
Stephen Wootton
Karl J. Staples
Tom M. A. Wilkinson
on behalf of the AERIS Study Group
author_sort Kristoffer Ostridge
title Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
title_short Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
title_full Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
title_fullStr Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
title_full_unstemmed Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
title_sort relationship of ct-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in copd
publisher BMC
series Respiratory Research
issn 1465-993X
publishDate 2018-02-01
description Abstract Background COPD is a complex, heterogeneous disease characterised by progressive development of airflow limitation. Spirometry provides little information about key aspects of pathology and is poorly related to clinical outcome, so other tools are required to investigate the disease. We sought to explore the relationships between quantitative CT analysis with functional, inflammatory and infective assessments of disease to identify the utility of imaging to stratify disease to better predict outcomes and disease response. Methods Patients from the AERIS study with moderate-very severe COPD underwent HRCT, with image analysis determining the quantity of emphysema (%LAA<− 950), small airways disease (E/I MLD) and bronchial wall thickening (Pi10). At enrolment subjects underwent lung function testing, six-minute walk testing (6MWT), blood sampling for inflammatory markers and sputum sampling for white cell differential and microbiological culture and PCR. Results 122 subjects were included in this analysis. Emphysema and small airways disease had independent associations with airflow obstruction (β = − 0.34, p < 0.001 and β = − 0.56, p < 0.001). %LAA<− 950 had independent associations with gas transfer (β = − 0.37, p < 0.001) and E/I MLD with RV/TLC (β = 0.30, p =0.003). The distance walked during the 6MWT was not associated with CT parameters, but exertional desaturation was independently associated with emphysema (β = 0.73, p < 0.001). Pi10 did not show any independent associations with lung function or functional parameters. No CT parameters had any associations with sputum inflammatory cells. Greater emphysema was associated with lower levels of systemic inflammation (CRP β = − 0.34, p < 0.001 and fibrinogen β = − 0.28, p =0.003). There was no significant difference in any of the CT parameters between subjects where potentially pathogenic bacteria were detected in sputum and those where it was not. Conclusions This study provides further validation for the use of quantitative CT measures of emphysema and small airways disease in COPD as they showed strong associations with pulmonary physiology and functional status. In contrast to this quantitative CT measures showed few convincing associations with biological measures of disease, suggesting it is not an effective tool at measuring disease activity.
topic COPD
CT
Imaging
Phenotyping
Emphysema
url http://link.springer.com/article/10.1186/s12931-018-0734-y
work_keys_str_mv AT kristofferostridge relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT nicholaspwilliams relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT viktoriyakim relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT stephenharden relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT simonbourne relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT stuartcclarke relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT emmanuelaris relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT soniamesiavela relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT jeannemariedevaster relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT andrewtuck relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT anthonywilliams relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT stephenwootton relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT karljstaples relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT tommawilkinson relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
AT onbehalfoftheaerisstudygroup relationshipofctquantifiedemphysemasmallairwaysdiseaseandbronchialwalldimensionswithphysiologicalinflammatoryandinfectivemeasuresincopd
_version_ 1725217368952537088